Clinical Trial Update: NAD Supplementation and Vascular Health in PAD [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of Phase 1 and Phase 2 studies assessing nicotinamide adenine dinucleotide (NAD) supplementation for vascular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Nicotinamide adenine dinucleotide (NAD) supplement (nicotinamide adenine dinucleotide)

Snippet

Sponsor: University of Oklahoma | Conditions: Peripheral Artery Disease | Phase 1, Phase 2 | Status: COMPLETED